Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

Autor: P.L. Meroni, T. Avcin, V. Medeghini, A. Meini, A. Lojacono, M. Frassi, M. Nuzzo, Z. Shums, W.L. Binder, G.L. Norman, M. Motta, L. Andreoli, C. Nalli, A. Tincani

Publikováno v: Reumatismo, Vol 63, Iss 2, Pp 91-96 (2011)

Objective: Anti-b2 GPI are a formal laboratory criterion for the antiphospholipid syndrome (APS). They were demonstrated to be a risk factor for thrombosis and fetal losses but can also be detected in patients with systemic autoimmune disease (SAD),

Externí odkaz: https://doaj.org/article/6fe84dc75328473cacaf5b79710a15f4

MELAS syndrome: Insights into cardiac mechanics.

Autor: Burattini M; Department of Surgery, Dentistry and Maternity, University of Verona, Verona, Italy; TecMedLab, Department of Medicine and Surgery, University of Parma, Parma, Italy., Pisano A; Department of Radiological, Oncological and Pathological Sciences, 'Sapienza' University of Rome, Roma, Italy., Medeghini V; TecMedLab, Department of Medicine and Surgery, University of Parma, Parma, Italy., Rossi S; TecMedLab, Department of Medicine and Surgery, University of Parma, Parma, Italy., Luciani GB; Department of Surgery, Dentistry and Maternity, University of Verona, Verona, Italy., D'Amati G; Department of Radiological, Oncological and Pathological Sciences, 'Sapienza' University of Rome, Roma, Italy., Miragoli M; TecMedLab, Department of Medicine and Surgery, University of Parma, Parma, Italy; Humanitas Research Hospital - IRCCS, Rozzano (Milan), Italy.

Publikováno v: Vascular pharmacology [Vascul Pharmacol] 2024 Jun; Vol. 155, pp. 107303.

The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.

Autor: Fickentscher C; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany., Magorivska I; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany ; Institute of Cell Biology, National Academy of Sciences of Ukraine, Drahomanov Street 14/16, Lviv 79005, Ukraine., Janko C; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany ; Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), University Hospital, Waldstraße 1/Glückstraße 10, 91054 Erlangen, Germany., Biermann M; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany., Bilyy R; Institute of Cell Biology, National Academy of Sciences of Ukraine, Drahomanov Street 14/16, Lviv 79005, Ukraine., Nalli C; Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy., Tincani A; Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy., Medeghini V; Paediatric Immunology and Rheumatology, Children's Hospital Brescia, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy., Meini A; Paediatric Immunology and Rheumatology, Children's Hospital Brescia, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy., Nimmerjahn F; Department of Biology, Institute of Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erwin-Rommel Str. 3, 91058 Erlangen, Germany., Schett G; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany., Muñoz LE; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany., Andreoli L; Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy., Herrmann M; Department for Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054 Erlangen, Germany.

Publikováno v: Journal of immunology research [J Immunol Res] 2015; Vol. 2015, pp. 638129. Date of Electronic Publication: 2015 Jun 22.